IndraLab

Statements

Spironolactone inhibits CTSB. 1 / 1

| 1

reach

"Multilevel blocking of the RAA system significantly increased activity of cathepsin B in homogenates of glomerular in diabetic rats treated with spironolactone (P = 0.02) and in combination with therapy with losartan and enalapril (P = 0.001) compared to the untreated diabetic rats."

26089895

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Spironolactone inhibits CTSB. 1 / 1

INDRA sources:

Databases

Reading